Berwyn, PA, United States of America

David James Ballance

This inventor holds 19 USPTO granted patents and 3 published patent applications and 5 EPO patents, primarily in Fusion Proteins. Top assignees: Human Genome Sciences, Inc., Novozymes Biopharma Dk A/s, Albumedix A/s. Active years: 2006-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David James Ballance. Retrieved from https://idiyas.com/inventor/david-james-ballance

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 19 

% Patents Active = 26.3

 

Average Co-Inventor Count = 2.7

ph-index = 10

Forward Citations = 572(Granted Patents)


Location History:

  • Nottingham, GB (2006 - 2014)
  • Berwyn, PA (US) (2006 - 2018)

Company Filing History:


Years Active: 2006-2018

Loading Chart...
Loading Chart...
Areas of Expertise:
Albumin Fusion Proteins
Recombinant Fusion Proteins
Factor VII-albumin
Factor IX-albumin
G-CSF-albumin
Exendin Fusion Protein
Transferrin Polypeptide
GLP-1 Polypeptides
Purification Processes
19 patents (USPTO):Explore Patents

Title: The Innovative Journey of David James Ballance

Introduction

David James Ballance is an accomplished inventor based in Berwyn, Pennsylvania, with an impressive portfolio of 19 patents to his name. His work primarily focuses on the development of albumin fusion proteins, showcasing his significant contributions to the field of biotechnology and pharmaceuticals.

Latest Patents

Among Ballance's most recent innovations are his patents on albumin fusion proteins, which encompass various aspects of their development and application. The invention details the nucleic acid molecules that encode these fusion proteins, vectors containing these nucleic acids, and host cells transformed with these vectors. Furthermore, it includes methods for producing the albumin fusion proteins and employing them in therapeutic contexts. Notably, his invention also comprises pharmaceutical compositions that utilize these proteins and outlines methods for treating, preventing, or ameliorating various diseases, disorders, or conditions.

Career Highlights

Throughout his career, David has worked with prominent companies in the biotechnology sector, including Human Genome Sciences, Inc. and Novozymes Biopharma Dk A/S. His expertise in protein engineering and molecular biology has allowed him to contribute significantly to advancements in therapeutic strategies and drug development.

Collaborations

David has collaborated with esteemed colleagues such as Andrew J. Turner and Darrell Sleep, which has facilitated the exchange of innovative ideas and fostered a productive research environment. These collaborations have further enriched his work and enhanced the potential impact of his inventions in the pharmaceutical domain.

Conclusion

David James Ballance's dedication to innovation in the field of albumin fusion proteins exemplifies the vital role of inventors in healthcare advancements. His patents not only reflect his ingenuity but also contribute to the broader goal of improving treatment options for various medical conditions. With a track record of collaboration and professional excellence, Ballance stands as a leading figure in his industry, pushing the boundaries of scientific research and application.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…